Indications to respiratory syncytial virus immunoprophylaxis in the 29–32 wGA group: is there still room for debating?
Crossref DOI link: https://doi.org/10.1186/S13052-017-0341-4
Published Online: 2017-02-02
Published Print: 2017-12
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Zuccotti, Gianvincenzo
Fabiano, Valentina
